Hypertriglyceridemic Pancreatitis: Conventional Treatment Versus Therapeutic Plasma Exchange
DOI:
https://doi.org/10.24950/rspmi.730Keywords:
Acute Disease, hypertriglyceridemia/therapy, Pancreatitis/ therapy, Plasma ExchangeAbstract
Introduction: Acute pancreatitis (AP) induced by hypertriglyceridemia
(HTG) can be treated with therapeutic plasma exchange
(TPE), resulting in rapid reduction of triglyceride level.
However, there are no definitive comparative studies that
prove the real benefits of this therapy.
Objectives: Comparison of treatment methods (TPE versus
conventional) in patients with HTG AP during a period of 12
years (2000-2012).
Methods: Retrospective, descriptive and inferential analysis of
37 patients, evaluating: gender, age, personal pathologic history,
severity of disease, HTG values and evolution depending
on treatment with therapeutic plasma exchange (“TPE”) or
with conventional therapy (“C”).
Results: Both groups TPE and C demonstrated homogeneity
considering gender (p = 0.647), age (43.5 ± 9.74 years TPE vs
45.30 ± 9.90 years C; p = 0.320), prior AP episode (40% TPE
vs 40.7% C; p = 1.0), chronic alcohol consumption (50% TPE
vs 70.4% C; p = 0.275) and severity disease scores: APACHE
II (p = 0.054) and Ranson (p = 0.258). More than one secondary
HTG risk factor was presented in 45.95% of patients
. TPE group presented higher TG levels at admission: 4850
± 2802 mg/dL vs 1845 ± 1858 mg/dL (p = 0.001). No significant
statistical differences were observed considering length
of hospital stay [14.2 ± 6.8 days vs 13.5 ± 9.0 days (p = 0.56)]
or mortality rate (p = 0.47). At discharge, TG reduction was
greater in TPE group: 4433.70 ± 2896.08 mg/dL – 91.41% vs
1582.95 ± 2051.06 mg/dL – 83,92% (p = 0.002). Six minor
complications associated to TPE occurred.
Discussion/Conclusion: Despite the selection bias (retrospective
study), a greater TG reduction was observed with TPE
technique. Complications associated with the technique were
simple to resolve.
Downloads
References
Claudia Stefanutti, Serafina Di Giacomo, Antonio Vivenzio, Giancarlo Labbadia, Fabio Mazza, Giovanna D’Alessandri, et al. Therapeutic plasma exchange in patients with severe hypertriglyceridemia: a multicenter study. Artif Organs. 2009; 33:1096–1102.
Kumaravel A, Stevens T, Papachristou GI, Muddana V, Bhatt A, Lee PJ, et al. Pancreas, biliary tract, and liver a model to predict the severity of acute pancreatitis based on serum level of amylase and body mass index. Clin Gastroenterol Hepatol. 2015;13:1496–501.
Valdivielso P, Ramírez-Bueno A, Ewald N. Current knowledge of hypertriglyceridemic pancreatitis. Eur J Intern Med. 2014;25:689–94.
Criddle DN. The role of fat and alcohol in acute pancreatitis: A dangerous liaison. Pancreatology. 2015;15:S6–12.
Xiao-Li Zhang, Fei Li, Ya-Min Zhen, Ang Li, Yu Fang. Clinical Study of 224 Patients with Hypertriglyceridemia 2015. Chin Med J. 2015; 128:2045-9.
Zeitler H, Balta Z, Klein B, Strassburg CP. Extracorporeal treatment in severe hypertriglyceridemia-induced pancreatitis. Ther Apher Dial. 2015; 19:405–10.
Click B, Ketchum AM, Turner R, Whitcomb DC, Papachristou GI, Yadav D. The role of apheresis in hypertriglyceridemia-induced acute pancreatitis: A systematic review. Pancreatology. 2015;15:313–20.
D, Pitchumoni CS. Hyperlipidemia in pancreatitis versus pancreatitis of hyperlipidemia. J Clin Gastroenterol. 2003;36:54–62.
Berglund L, Brunzell JD, Goldberg AC, Goldberg IJ, Stalenhoef A. Treatment options for hypertriglyceridemia: from risk reduction to pancreatitis. Best Pract Res Clin Endocrinol Metab. 2014;28:423–37.
Galán Carrillo I, Demelo-Rodriguez P, Rodríguez Ferrero ML, Anaya F. Double filtration plasmapheresis in the treatment of pancreatitis due to severe hypertriglyceridemia. J Clin Lipidol. 2015;9:698–702.
Toth PP, Grabner M, Ramey N, Higuchi K. Clinical and economic outcomes in a real-world population of patients with elevated triglyceride levels. Atherosclerosis. 2014;237:790–7.
Scherer J, Singh V, Pitchumoni CS, Yadav D. Issues in hypertriglyceridemic pancreatitis -an update. J Clin Gastroenterol. 2014 ; 48: 195–203.
Valme U De, Valme HU De, Intensivos UDC. Uso de la plasmaféresis en la pancreatitis aguda hipertrigliceridémica Plasmapheresis in hypertriglyceridemic acute pancreatitis. Med Intensiva. 2015 ;39:387-8.
Maher NG, Ramaswamykanive H. Case report use of plasmapheresis inmanaging the diagnostic dilemma of symptomatic hypertriglyceridemia. Case Rep Gastrointest Med. 2012;2012:501373.
Lalastra CS, Hernández ET, Vicente VM, Castellanos MM, Concepción M, et al. Pancreatitis aguda por hipertrigliceridemia. Gastroenterol Hepatol. 2013;36:274–9.
Ramírez-Bueno A, Salazar-Ramírez C, Cota-Delgado F, De La Torre-Prados M V, Valdivielso P. Plasmapheresis as treatment for hyperlipidemic pancreatitis. Eur J Intern Med. 2014;25:160–3.
Winters JL. Plasma exchange: concepts, mechanisms, and an overview of the American Society for Apheresis guidelines. Hematol Am Soc Hematol Educ Program. 2012;2012:7-12.
Suvarna R, Pallipady A, Bhandary N, Hanumanthappa H. The clinical prognostic indicators of acute pancreatitis by APAChe II Scoring. J Clin Diagn Res. 2011;5:459–63.
Schwartz J, Winters JL, Padmanabhan A, Balogun RA, Delaney M, Linenberger ML, et al. Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Writing Committee of the American Society for Apheresis: the sixth special issue. J Clin Apher. 2013;28:145-284.
Chen JH, Yeh JH, Lai HW, Liao CS. Therapeutic plasma exchange in patients with hyperlipidemic pancreatitis. World J Gastroenterol.
;10:2272-4.
Additional Files
Published
How to Cite
Issue
Section
License
Copyright (c) 2017 Medicina Interna
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2023 Medicina Interna